Finance

Lists
Why is OTLK up 6,19%?
Dive Deeper
OTLK:NASDAQ
Outlook Therapeutics Inc
0,60 $
+6,19%
(+0,035) 1D
0,59 $
-1,47% (-0,0088)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
0,57 $
High
0,60 $
Low
0,56 $
Mkt. cap
146,84 մլն
Avg. vol.
4,80 մլն
Volume
3,69 մլն
52-wk high
2,54 $
52-wk low
0,16 $
EPS
-0,87 $
Beta
0,66
Shares outstanding
243,45 մլն
No. of employees
17
Open
0,57 $
High
0,60 $
Low
0,56 $
Mkt. cap
146,84 մլն
Avg. vol.
4,80 մլն
Volume
3,69 մլն
52-wk high
2,54 $
52-wk low
0,16 $
EPS
-0,87 $
Beta
0,66
Shares outstanding
243,45 մլն
No. of employees
17
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current 0,60 $
10,50 $ (+1 653,21%)
Average
5,37 $ (+796,64%)
Lowest
1,60 $ (+167,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
10,50 $
+1 653,2%
09/10/2026
Julian Harrison
BTIG
Buy
Reiterated
4,00 $
+567,9%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
1,60 $
+167,2%
07/28/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
1,00 $
+67%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-91,79 հզր
-1,21 մլն
127,44 հզր
8,70 հզր
Cost of goods sold
916,52 հզր
29,63 հզր
149,33 հզր
16,96 հզր
Cost of revenue
916,52 հզր
29,63 հզր
149,33 հզր
16,96 հզր
Research and development expenses
5,98 մլն
3,63 մլն
4,50 մլն
3,25 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,33 մլն
8,61 մլն
9,50 մլն
7,55 մլն
Operating expense
16,31 մլն
12,25 մլն
14,01 մլն
10,80 մլն
Total operating expenses
17,22 մլն
12,28 մլն
14,15 մլն
10,82 մլն
Operating income
-17,31 մլն
-13,48 մլն
-14,03 մլն
-10,81 մլն
Other non operating income
3,02 մլն
-2,79 մլն
6,84 մլն
-7,04 մլն
EBT including unusual items
-14,85 մլն
-23,06 մլն
-4,45 մլն
-20,32 մլն
EBT excluding unusual items
-14,51 մլն
-16,31 մլն
-7,23 մլն
-17,89 մլն
Income tax expense
-1,55 մլն
-
-
-
Effective tax rate
10,47%
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,29 մլն
-23,06 մլն
-4,45 մլն
-20,32 մլն
Net profit margin
14 482,19%
1 909,05%
-3 494,28%
-233 554,85%
Earnings per share
-0,29
-0,22
-0,17
-0,09
Interest and investment income
89,74 հզր
-
3,00
7,00
Interest expense
-264,16 հզր
-
-
-
Net interest expenses
-174,42 հզր
-
3,00
7,00
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,28 մլն
-13,45 մլն
-14,00 մլն
-10,80 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps